Cancer scientists overestimate the extent to which high-profile preclinical studies can be successfully replicated, new research from McGill University suggests.

Classified as: reproducibility, preclinical studies, Cancer, Reproducibility Project: Cancer Biology, Jonathan Kimmelman
Published on: 29 Jun 2017
Back to top